Erin Carter
Independent DirectorMs. Erin Carter serves as Independent Director of GlucoTrack, Inc. since August 25, 2023. She served as Director of Finance at BÂRRX Medical, Inc. Ms. Carter Joined Covidien in 2012 as Director of Finance for GI Solutions. She has experience in Accounting and Financial leadership roles in the Public Accounting and Medical Device industries. Ms. Carter (since November 2025) currently serves as the SVP of Corporate Development and Strategic Finance for Masimo Corporation. Her experience ranges from Pre-IPO companies to industry leading multi-billion dollar operations. Prior to Joining Covidien, she served as a Director of Finance for Boston Scientific. From 2012 until March of 2023, she held various senior roles with Medtronic, most recently serving as Chief Financial Officer and Vice President of Finance. From 2023 to 2025, she served as the Chief Financial Officer for the Mayo Collaborative Services, at the Mayo Clinic. Mayo Collaborative Services facilitates access to the Mayo Clinic diagnostic expertise and services. Prior to Medtronic, Ms. Carter served as VP of Accounting and Reporting at UnitedHealth Group. Prior to that, she served as Assistant Controller for Arterial Vascular Engineering. She has led international accounting operations, cost accounting, consolidations and FP&A teams. She began her career in Auditing with Coopers & Lybrand, LLC. She is a CPA (inactive California) and holds a B.S in Accounting and Business Administration from California Polytechnic University at San Luis Obispo.
Positions
- Company NameGlucoTrack, Inc.Stock CodeGCTKPositionIndependent Director
